Bactiguard Holding AB (publ) (FRA:5JE)

Market Cap	50.53M -58.5%
Revenue (ttm)	18.33M -17.5%
Net Income	-790.86K
EPS	-0.02
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	1.350
Previous Close	1.300
Day's Range	1.350 - 1.350
52-Week Range	1.230 - 3.310
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Jul 14, 2026

About Bactiguard Holding AB

Bactiguard Holding AB (publ), a medTech company, provides infection prevention technology and solutions in orthopedics, cardiology, neurology, urology, and vascular access areas. The company also has a portfolio of wound management products, such as Hydrocyn Aqua, an antimicrobial solution and gel for acute, chronic, and infected wounds; and surgical sutures comprising non-absorbable, natural absorbable, synthetic absorable, and specialty sutures. It also operates through license partnerships with global MedTech companies that apply the technol...

• Industry: Orthopedic, Prosthetic, and Surgical Appliances and Supplies
• Founded: 2005
• Employees: 168
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 5JE

Financial Performance

In 2025, Bactiguard Holding AB's revenue was 217.78 million, a decrease of -10.63% compared to the previous year's 243.68 million. Losses were -7.84 million, -73.69% less than in 2024.

Financial numbers in SEK